Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20(+) B-cell non-Hodgkin's lymphoma (Q73218725)
Jump to navigation
Jump to search
scientific article published on 01 December 1999
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20(+) B-cell non-Hodgkin's lymphoma |
scientific article published on 01 December 1999 |
Statements
Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20(+) B-cell non-Hodgkin's lymphoma (English)
T E Witzig
C A White
G A Wiseman
L I Gordon
C Emmanouilides
A Raubitschek
N Janakiraman
J Gutheil
R J Schilder
S Spies
D H Silverman
E Parker
A J Grillo-López